PRESS RELEASE published on 01/24/2023 at 13:30, 2 years 11 months ago Sterling Metals Strengthens Team with Key Appointments
Published on 01/23/2026 at 23:30, 1 hour 4 minutes ago CORRECTION FROM SOURCE: IBC Announces Incentive Stock Option Awards
Published on 01/23/2026 at 23:20, 1 hour 14 minutes ago Silver Tiger Announces Filing of a PEA for the Underground and an Updated Pre-Feasibility Study Technical Report for the El Tigre Silver-Gold Project
Published on 01/23/2026 at 23:10, 1 hour 24 minutes ago Early Warning Press Release – Acquisitions by Pierre Lassonde in Fuerte Metals
Published on 01/23/2026 at 22:01, 2 hours 33 minutes ago Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
Published on 01/23/2026 at 16:40, 7 hours 54 minutes ago Excalibur IP Survey Results Confirm High Priority Copper Gold Drill Targets
Published on 01/23/2026 at 21:21, 3 hours 13 minutes ago EQS-Adhoc: LR Health & Beauty SE: PRELIMINARY RESULTS FOR FINANCIAL YEAR 2025 / TARGETED EQUITY CONTRIBUTION / TARGETED RESTRUCTURING OF THE 2024/2028 BONDS
Published on 01/23/2026 at 19:42, 4 hours 52 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA concludes standstill agreement with creditors of significant financing arrangements
Published on 01/23/2026 at 19:02, 5 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/23/2026 at 18:50, 5 hours 44 minutes ago Mercedes-AMG PETRONAS F1 Team Announces Collaboration Agreement with Zuma
Published on 01/23/2026 at 15:45, 8 hours 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 01/22/2026 at 17:40, 1 day 6 hours ago Disclosure of shares outstanding and voting rights - 22.01.2026
Published on 01/22/2026 at 08:45, 1 day 15 hours ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:29, 1 day 16 hours ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies